Home FOR AUTHORS Endocrine Regulations 2014 Endocrine Regulations Vol.48, No.3, p.126-134, 2014

Journal info

Quarterly, 50 pp. per issue 
Founded: 1967
ISSN 1210-0668
E-ISSN 1336-0329

Published in English

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Endocrine Regulations Vol.48, No.3, p.126-134, 2014

Title: The effect of ghrelin antagonist (D-Lys3) GHRP-6 on ovariectomy-induced obesity in adult female albino rats
Author: S. M. Abdel-Hakim, M. Y. Ibrahim, H. M. Ibrahim, M. M. Ibrahim
Abstract: Objective. We aimed to investigate the effect of ghrelin antagonist (D-Lys3) GHRP-6 on the treatment of ovariectomy-induced obesity as compared to hormone replacement therapy with estradiol.
Methods. Twenty eight rats were divided into four groups: control sham operated (C), ovariectomized non-treated (OVX), ovariectomized+estradiol-treated (OVX+E) groups, and ovariectomized+ghrelin antagonist-treated group (OVX+GA). Rats were allowed free water and commercial standard diet ad libitum for 5 weeks after surgery. Body mass index (BMI) was determined at the beginning and the end of the experiment. Rats were sacrificed by decapitation and blood samples were collected for measurements of serum lipid profile, insulin, and glucose levels. Gastrocolic omental fat (GCOF) was removed and weighed.
Results. Ovariectomy was accompanied with a significantly higher body weight, food intake, BMI, GCOF, serum total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), glucose, insulin, and homeostatic model assessment – insulin resistance (HOMA-IR), with a significant decrease in high density lipoprotein-cholesterol (HDL-C) and triglycerides (TGs) in comparison with C group. Estradiol reversed the ovariectomy-induced changes except that of TGs. Administration of ghrelin antagonist was effective in treating the ovariectomy-induced obesity as evidenced by normalization of body weight, food intake, BMI, and GCOF weight, serum levels of insulin, glucose, HOMA-IR, and HDL-C. The serum levels of TC, LDL-C and TGs were improved but did not reach the control values.
Conclusion. Although estradiol succeeded in the prevention of almost all ovariectomy-induced disturbances, it had a potential cardiovascular risk due to a marked increase in serum TGs. Ghrelin antagonist was effective in ameliorating ovariectomy-induced obesity, so it may be used as a promising treatment for postmenopausal obesity, irrespective of hormonal replacement.
Keywords: ovariectomy, obesity, ghrelin, rat
Year: 2014, Volume: 48, Issue: 3 Page From: 126, Page To: 134
doi:10.4149/endo_2014_03_126
Price: 18.00 €





© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.